S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94

Checkpoint Therapeutics Insider Trades

+0.19 (+17.43%)
(As of 05/13/2022 06:55 PM ET)
Today's Range
50-Day Range
52-Week Range
1.22 million shs
Average Volume
1.29 million shs
Market Capitalization
$115.96 million
P/E Ratio
Dividend Yield

Checkpoint Therapeutics (NASDAQ:CKPT) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Number Of
Insiders Selling
(Last 12 Months)
Amount Of
Insider Selling
(Last 12 Months)
$351.89 K

Insider Buying and Selling by Quarter

Get CKPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Checkpoint Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Checkpoint Therapeutics (NASDAQ:CKPT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/13/2022James F Oliviero IIICEOSell21,258$1.51$32,099.582,838,003  
4/4/2022James F Oliviero IIICEOSell86,353$1.79$154,571.872,873,291  
3/10/2022William Garrett GrayCFOSell38,197$1.89$72,192.33  
2/1/2022William Garrett GrayCFOSell37,063$2.51$93,028.13  
2/4/2021James F. Oliviero IIICEOSell70,000$3.51$245,700.00  
2/4/2021William Garrett GrayCFOSell26,320$3.66$96,331.20  
12/22/2020William Garrett GrayCFOSell2,406$2.79$6,712.74  
11/20/2019Lindsay A Md RosenwaldDirectorBuy100,000$1.40$140,000.00
11/9/2018Lindsay A Md RosenwaldDirectorBuy100,000$2.29$229,000.00  
(Data available from 1/1/2013 forward)

Checkpoint Therapeutics (NASDAQ:CKPT) Insider Trade Frequently Asked Questions

Who is on Checkpoint Therapeutics's Insider Roster?

The list of insiders at Checkpoint Therapeutics includes James F Oliviero III, Lindsay A Md Rosenwald, and William Garrett Gray. Learn more on insiders at CKPT.

What percentage of Checkpoint Therapeutics stock is owned by insiders?

6.10% of Checkpoint Therapeutics stock is owned by insiders. Learn more on CKPT's insider holdings.

Which Checkpoint Therapeutics insiders have been selling company stock?

The following insiders have sold Checkpoint Therapeutics stock in the last 24 months: James F Oliviero III ($186,671.45), and William Garrett Gray ($268,264.40).

How much insider selling is happening at Checkpoint Therapeutics?

Insiders have sold a total of 281,597 Checkpoint Therapeutics shares in the last 24 months for a total of $700,635.85 sold.

This page was last updated on 5/16/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.